Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin. (11th November 2019)

• Record Type: Journal Article
• Authors: Deng, Min; Xue, Yongju; Xu, Lerong; Wang, Qiangwu; Wei, Jun; Ke, Xiquan; Wang, Jianchao; Chen, Xiaodong
• Is Part Of: Cell biochemistry and function. Volume 38:Number 1(2020)
• Page Start: 47
• Page End: 57
• Publication Date: 2019-11-11
• Subjects: Chrysophanol -- Colorectal cancer -- Decorin; Cytochemistry -- Periodicals; Cell metabolism -- Periodicals; Biochemistry -- Periodicals; Cytology -- Periodicals; 572
• DOI: 10.1002/cbf.3445
• Languages: English
• ISSNs: 0263-6484

Abstract

Abstract : Colorectal cancer (CRC) is a common human malignancy that accounts for 600, 000 deaths annually worldwide. Chrysophanol, a naturally occurring anthraquinone compound, exhibits anti‐neoplastic effects in various cancer cells. The aim of this study was to explore the biological effects of chrysophanol on CRC cells, and determine the underlying mechanism. Chrysophanol inhibited proliferation of and promoted apoptosis in CRC cells by activating the intrinsic mitochondrial apoptotic pathway. In addition, chrysophanol also suppressed tumor growth in vivo and increased the percentage of apoptotic cells in tumor xenografts, without general toxicity. Proteomic iTRAQ analysis revealed decorin (DCN) as the major target of chrysophanol. DCN was upregulated in the tumor tissues following chrysophanol treatment, and ectopic DCN expression markedly augmented the pro‐apoptotic effects of chrysophanol in CRC cells. In contrast, DCN knockdown significantly abrogated chrysophanol‐induced apoptosis in CRC cells. Taken together, chrysophanol exerts anti‐neoplastic effects in vitro and in vivo in CRC cells by modulating DCN, there by highlighting its therapeutic potential in CRC.